Extra Super Cialis
Extra Super Cialis Price range: $ 102,00 through $ 545,00
Back to products
Extra Super P-Force
Extra Super P-Force Price range: $ 72,00 through $ 199,00

Extra Super Levitra

Price range: $ 99,00 through $ 530,00

Extra Super Levitra is a potent dual-action medication specifically formulated to address both erectile dysfunction and premature ejaculation in one convenient tablet. This innovative blend combines Vardenafil for improved blood flow with Dapoxetine to enhance control over the timing of climax. By targeting these two key aspects of male performance, the treatment helps ensure a firm, reliable erection while significantly extending the duration of intimacy. It provides a comprehensive solution for men looking to boost their sexual health and regain confidence in their physical capabilities. This high-quality pharmaceutical option offers a balanced approach to achieving a more fulfilling and satisfying personal life.

Active substance: Dapoxetine, Vardenafil
SKU: Extra Super Levitra Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Extra Super Levitra: What You Need to Know

Extra Super Levitra belongs to a class of combination pharmacological agents containing a phosphodiesterase type 5 (PDE5) inhibitor alongside a selective serotonin reuptake inhibitor (SSRI). The product combines vardenafil hydrochloride and dapoxetine hydrochloride into a single oral solid dosage form. This dual-acting therapeutic strategy is designed to address two distinct aspects of male sexual dysfunction simultaneously.

In the United States, medications containing PDE5 inhibitors are classified as prescription (Rx) agents that require direct medical evaluation, while dapoxetine is an investigational SSRI in this jurisdiction. Consequently, this combination formulation is dispensed in accordance with applicable federal and state regulations governing prescription-strength active pharmaceutical ingredients. Proper administration requires precise medical oversight to evaluate cardiovascular safety and potential neurochemical interactions.

Parameter Specification
Active ingredients (INN) Vardenafil hydrochloride / Dapoxetine hydrochloride
Therapeutic class PDE5 Inhibitor / Selective Serotonin Reuptake Inhibitor (SSRI)
Dosage form Oral film-coated tablet
Route of administration Oral
Primary purpose Management of erectile dysfunction and premature ejaculation
Prescription status Dispensed in accordance with applicable federal and state regulations

Main uses

Extra Super Levitra is indicated for the treatment of adult men presenting with co-occurring erectile dysfunction (ED) and premature ejaculation (PE). The vardenafil component addresses the vascular deficits associated with erectile difficulty by facilitating penile arterial engorgement. Concurrently, the dapoxetine component targets the neurochemical mechanisms governing ejaculatory latency. While vardenafil acts upon peripheral vascular tissue, dapoxetine exerts central nervous system effects. The combination is prescribed when a clinician determines that both physiological pathways require pharmacologic intervention in a single regimen.

How the drug works

The mechanism of action relies on two independent pathways. Vardenafil acts as a potent, selective inhibitor of cGMP-specific phosphodiesterase type 5 (PDE5). By inhibiting PDE5, vardenafil prevents the degradation of cyclic guanosine monophosphate (cGMP) in the vascular smooth muscle of the corpus cavernosum. Elevated cGMP levels induce smooth muscle relaxation and arterial inflow during sexual stimulation. Dapoxetine acts by inhibiting the neuronal reuptake of serotonin (5-hydroxytryptamine or 5-HT) and subsequently enhancing serotonin’s action at pre- and postsynaptic receptors. Increased serotonergic signaling within the central nervous system delays the ejaculatory reflex at the supraspinal level.

How it’s absorbed and eliminated

Following oral administration, vardenafil is rapidly absorbed, achieving peak plasma concentration (Cmax) within 30 to 120 minutes under fasted conditions. Vardenafil exhibits an absolute bioavailability of approximately 15% due to first-pass hepatic metabolism via the cytochrome P450 (CYP) 3A4 enzyme system. Its primary elimination half-life ranges from 4 to 5 hours, with metabolites primarily excreted via the feces (roughly 88%) and secondarily through urine. Dapoxetine is rapidly absorbed as well, reaching peak concentrations within 1 to 2 hours post-dose. Dapoxetine undergoes extensive hepatic clearance via CYP2D6 and CYP3A4 pathways. It displays a biphasic elimination profile, with an initial rapid clearance half-life of approximately 1.5 hours and a terminal half-life of roughly 19 hours, preventing significant drug accumulation upon intermittent use.

Dosing schedule

The administration schedule for Extra Super Levitra must be established individually by a qualified prescriber. The tablet is taken orally with a full glass of water approximately 1 to 3 hours prior to anticipated sexual activity. It is not intended for continuous daily administration; instead, it is used on an as-needed basis. Dosing frequency must not exceed one tablet within a 24-hour period. Dosage adjustments may be required by a physician based on individual clinical response, hepatic function, renal clearance, and tolerability.

What you may notice early on

Patients initiating therapy may observe physiological responses related to both active components shortly after administration. Vardenafil requires sexual stimulation to manifest its pharmacologic effect; the medication does not spontaneously induce erections without neural trigger mechanisms. Patients may notice transient facial warmth or mild nasal fullness as peripheral vasodilation occurs. Regarding ejaculatory control, dapoxetine acts acutely, meaning improvements in ejaculatory latency are generally observed during the initial dose rather than requiring weeks of steady-state accumulation typical of chronic SSRI therapy.

What to avoid while taking it

To ensure patient safety, specific dietary substances and chemical compounds must be avoided during treatment. High-fat meals should be avoided prior to administration, as heavy lipid content can significantly delay gastric emptying and slow the systemic absorption rate of vardenafil. Grapefruit juice and grapefruit products must be completely avoided; grapefruit compounds inhibit the hepatic CYP3A4 isoenzyme, leading to elevated plasma levels of both vardenafil and dapoxetine and increasing the probability of toxicity. Ethanol (alcohol) must not be consumed concurrently, as alcohol potentiates central nervous system depression, accentuates dapoxetine-induced orthostatic hypotension, and increases the risk of syncope (fainting).

Compatibility with other medicines

Extra Super Levitra exhibits critical pharmacodynamic and pharmacokinetic interactions with several drug classes:

  • Nitrates and Nitric Oxide Donors: Concomitant administration with organic nitrates (e.g., nitroglycerin, isosorbide mononitrate) or soluble guanylate cyclase stimulators (e.g., riociguat) is strictly contraindicated due to severe, potentially fatal drops in systemic blood pressure.
  • Monoamine Oxidase Inhibitors (MAOIs) and Serotonergic Agents: Co-administration with MAOIs, thioridazine, SSRIs, SNRIs, or tricyclic antidepressants is contraindicated due to the risk of Serotonin Syndrome. A 14-day washout period is required when switching between these agents and dapoxetine.
  • CYP3A4 Inhibitors: Potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, clarithromycin) significantly decrease the clearance of both active substances, increasing systemic toxicity risk.
  • Alpha-Blockers: Concomitant use with alpha-adrenergic antagonists (e.g., tamsulosin, doxazosin) used for hypertension or benign prostatic hyperplasia requires clinical stabilization, as combined vasodilatory actions may induce symptomatic hypotension.

Adverse reactions

Adverse effects observed with Extra Super Levitra stem from the combined pharmacological profiles of vardenafil and dapoxetine. The severity and frequency of reactions vary among individuals.

  • Vascular and Neurological: Headache, transient facial flushing, dizziness, and somnolence.
  • Gastrointestinal: Dyspepsia (upset stomach), nausea, abdominal discomfort, and diarrhea.
  • Otorhinolaryngologic: Nasal congestion, rhinitis, and sinus pressure.
  • Psychiatric/Central Nervous System: Restlessness, mild anxiety, insomnia, or vivid dreams associated with serotonergic activity.
  • Ophthalmic: Visual color distortions (cyanopsia) or increased light sensitivity.

Important precautions

Pre-existing cardiovascular status must be rigorously evaluated before initiation. Patients with recent myocardial infarction, unstable angina, severe heart failure, or stroke within the preceding six months should not utilize this agent. Special caution is warranted in patients with anatomical penile deformities (e.g., Peyronie’s disease) or conditions predisposing to priapism (e.g., sickle cell anemia, multiple myeloma). Due to the dapoxetine component, patients with a history of orthostatic hypotension, bipolar disorder, mania, or unstable epilepsy require thorough medical assessment. Impaired hepatic or severe renal function mandates dose adjustment or complete avoidance depending on the degree of impairment.

Red flags

Certain adverse symptoms represent emergency conditions that require immediate medical evaluation. Patients experiencing these critical manifestations must discontinue the medication and seek acute medical care instantly.

Symptom Clinical Risk
Priapism (erection lasting > 4 hours) Irreversible tissue damage and permanent erectile dysfunction
Sudden vision loss in one or both eyes Non-arteritic anterior ischemic optic neuropathy (NAION)
Sudden hearing decrease or loss Ototoxicity / vascular compromise of the inner ear
Chest pain, severe dizziness, or syncope Severe cardiovascular events or profound hypotension
Signs of Serotonin Syndrome (fever, rigidity, confusion) Potentially life-threatening neurochemical toxicity

Frequently Asked Questions

Can Extra Super Levitra be taken on a daily schedule?

No, Extra Super Levitra is designed strictly for short-acting, as-needed use prior to anticipated sexual activity. It is not formulated or approved for continuous daily maintenance dosing. Exceeding a single dose in a 24-hour window substantially raises the concentration of both vardenafil and dapoxetine in the bloodstream, dramatically increasing the risk of adverse cardiovascular, neurological, and serotonergic reactions.

What should be done if dizziness or lightheadedness occurs after dosing?

Dizziness and lightheadedness can occur due to the combined blood pressure-lowering effect of vardenafil and the orthostatic effects of dapoxetine. If these symptoms manifest, sit or lie down immediately with legs elevated until the sensation subsides. Avoid standing up rapidly from a seated or lying position. If lightheadedness persists, worsens, or causes fainting (syncope), prompt emergency medical evaluation is necessary.

Is it safe to drive or operate machinery after taking this medication?

Patients are strongly advised against driving, operating heavy machinery, or performing hazardous tasks immediately after taking Extra Super Levitra. Both vardenafil and dapoxetine can induce central nervous system effects, including somnolence, altered reaction time, lightheadedness, and temporary visual disturbances. Assess your individual physiological reaction to the medication in a safe environment before attempting activities requiring focused alertness.

How does consuming a high-fat meal alter the onset of action?

Ingesting a meal high in fat shortly before taking Extra Super Levitra delays the rate of gastrointestinal absorption for vardenafil. This delay can postpone the clinical onset of action beyond the typical 30-to-120-minute window and lower peak plasma concentration. For optimal and predictable absorption, the medication is best administered either in a fasted state or after a light, low-fat meal.


Information on this page is for reference and does not replace an assessment by a licensed healthcare professional.

In accordance with FDA requirements.

Additional information
Dosage

40mg+60mg

Package

30 pills

,

40 pills

,

60 pills

,

120 pills

,

180 pills

Ενεργός Ουσία

,